Novel combinations of ion channel inhibitors for treatment of neurotrauma

Ryan O'Hare Doig, Melinda Fitzgerald

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Neurotrauma results in the progressive degeneration of neurons and glia surrounding the initial injury. Disruptions to myelin structure are a feature of these injuries and are thought to be triggered by excess calcium (Ca2+) influx into myelinating oligodendrocytes and/or their precursor cells. Calcium ions enter oligodendrocytes through a range of receptors including voltage gated calcium channels, N-methyl-D-aspartate (NMDA) receptors, Ca2+ permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and purinergic P2X7 receptors. Inhibitors have been used to limit excess Ca2+ entry following neurotrauma, but clinical success has been limited. We propose that combinations of calcium channel inhibitors may provide an alternative treatment strategy, whereby entry of excess Ca2+ flux through multiple routes is inhibited simultaneously.

LanguageEnglish
Pages41-47
Number of pages7
JournalDiscovery Medicine
Volume19
Issue number102
Publication statusPublished - 2015
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{c2dd38bf50b14efdb24a736f75b86d68,
title = "Novel combinations of ion channel inhibitors for treatment of neurotrauma",
abstract = "Neurotrauma results in the progressive degeneration of neurons and glia surrounding the initial injury. Disruptions to myelin structure are a feature of these injuries and are thought to be triggered by excess calcium (Ca2+) influx into myelinating oligodendrocytes and/or their precursor cells. Calcium ions enter oligodendrocytes through a range of receptors including voltage gated calcium channels, N-methyl-D-aspartate (NMDA) receptors, Ca2+ permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and purinergic P2X7 receptors. Inhibitors have been used to limit excess Ca2+ entry following neurotrauma, but clinical success has been limited. We propose that combinations of calcium channel inhibitors may provide an alternative treatment strategy, whereby entry of excess Ca2+ flux through multiple routes is inhibited simultaneously.",
author = "{O'Hare Doig}, Ryan and Melinda Fitzgerald",
year = "2015",
language = "English",
volume = "19",
pages = "41--47",
journal = "Discovery Medicine",
issn = "1539-6509",
publisher = "Discovery Medicine",
number = "102",

}

Novel combinations of ion channel inhibitors for treatment of neurotrauma. / O'Hare Doig, Ryan; Fitzgerald, Melinda.

In: Discovery Medicine, Vol. 19, No. 102, 2015, p. 41-47.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel combinations of ion channel inhibitors for treatment of neurotrauma

AU - O'Hare Doig, Ryan

AU - Fitzgerald, Melinda

PY - 2015

Y1 - 2015

N2 - Neurotrauma results in the progressive degeneration of neurons and glia surrounding the initial injury. Disruptions to myelin structure are a feature of these injuries and are thought to be triggered by excess calcium (Ca2+) influx into myelinating oligodendrocytes and/or their precursor cells. Calcium ions enter oligodendrocytes through a range of receptors including voltage gated calcium channels, N-methyl-D-aspartate (NMDA) receptors, Ca2+ permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and purinergic P2X7 receptors. Inhibitors have been used to limit excess Ca2+ entry following neurotrauma, but clinical success has been limited. We propose that combinations of calcium channel inhibitors may provide an alternative treatment strategy, whereby entry of excess Ca2+ flux through multiple routes is inhibited simultaneously.

AB - Neurotrauma results in the progressive degeneration of neurons and glia surrounding the initial injury. Disruptions to myelin structure are a feature of these injuries and are thought to be triggered by excess calcium (Ca2+) influx into myelinating oligodendrocytes and/or their precursor cells. Calcium ions enter oligodendrocytes through a range of receptors including voltage gated calcium channels, N-methyl-D-aspartate (NMDA) receptors, Ca2+ permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and purinergic P2X7 receptors. Inhibitors have been used to limit excess Ca2+ entry following neurotrauma, but clinical success has been limited. We propose that combinations of calcium channel inhibitors may provide an alternative treatment strategy, whereby entry of excess Ca2+ flux through multiple routes is inhibited simultaneously.

UR - http://www.scopus.com/inward/record.url?scp=84930967699&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 41

EP - 47

JO - Discovery Medicine

T2 - Discovery Medicine

JF - Discovery Medicine

SN - 1539-6509

IS - 102

ER -